New York State Common Retirement Fund Impel Pharmaceuticals Inc Transaction History

New York State Common Retirement Fund

  • $76.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$5.83 - $10.12 $39,655 - $68,836
-6,802 Reduced 99.34%
45 $0
Q1 2022

May 05, 2022
SELL
$5.86 - $9.85 $117 - $197
-20 Reduced 0.29%
6,847 $44,000
Q3 2021

Nov 02, 2021
SELL
$8.38 - $26.13 $57,260 - $178,546
-6,833 Reduced 49.88%
6,867 $84,000
Q2 2021

Aug 02, 2021
BUY
$7.33 - $15.2 $100,421 - $208,240
13,700 New
13,700 $121,000

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0
View Full List

About IMPEL PHARMACEUTICALS INC

IMPL Quotes by TradingView
  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email